posted on 2024-03-06, 14:14authored byDJ Adams, B Barlas, RE McIntyre, I Salguero, L van der Weyden, A Barros, JR Vicente, N Karimpour, A Haider, M Ranzani, G Turner, NA Thompson, V Harle, R Olvera-León, CD Robles-Espinoza, AO Speak, N Geisler, WJ Weninger, SH Geyer, J Hewinson, NA Karp, The Sanger Mouse Genetics Project, B Fu, F Yang, Z Kozik, J Choudhary, L Yu, MS van Ruiten, BD Rowland, CJ Lelliott, M del Castillo Velasco-Herrera, R Verstraten, L Bruckner, AG Henssen, MA Rooimans, J de Lange, TJ Mohun, MJ Arends, KA Kentistou, PA Coelho, Y Zhao, H Zecchini, JRB Perry, SP Jackson, G Balmus
Genomic instability arising from defective responses to DNA damage1 or mitotic chromosomal imbalances2 can lead to the sequestration of DNA in aberrant extranuclear structures called micronuclei (MN). Although MN are a hallmark of ageing and diseases associated with genomic instability, the catalogue of genetic players that regulate the generation of MN remains to be determined. Here we analyse 997 mouse mutant lines, revealing 145 genes whose loss significantly increases (n = 71) or decreases (n = 74) MN formation, including many genes whose orthologues are linked to human disease. We found that mice null for Dscc1, which showed the most significant increase in MN, also displayed a range of phenotypes characteristic of patients with cohesinopathy disorders. After validating the DSCC1-associated MN instability phenotype in human cells, we used genome-wide CRISPR-Cas9 screening to define synthetic lethal and synthetic rescue interactors. We found that the loss of SIRT1 can rescue phenotypes associated with DSCC1 loss in a manner paralleling restoration of protein acetylation of SMC3. Our study reveals factors involved in maintaining genomic stability and shows how this information can be used to identify mechanisms that are relevant to human disease biology1.
Funding
Crick (Grant ID: 10117, Grant title: Mohun FC001117)